Spire Healthcare Group
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
1.58K1.15K972.871.01K
Price/Sales ratio
61.4358.3055.6953.67
Earnings per Share (EPS)
Β£0.15Β£0.21Β£0.25Β£0.24

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
200.8020.8525.2060.474.36K79.05-2.66-103.31106.7533.2632.0979.05
Price/Sales ratio
1.401.411.451.090.460.580.670.900.760.660.620.46
Price/Book Value ratio
1.261.251.300.970.460.600.881.411.251.221.220.46
Price/Cash Flow ratio
10.668.057.618.192.393.084.395.875.724.544.122.39
Price/Free Cash Flow ratio
25.9627.3148.41211.654.004.596.549.8912.617.867.844.00
Price/Earnings Growth ratio
-2.100.03-1.89-0.89-43.850.000.001.07-0.560.1512.83-43.85
Dividend Yield
N/A0.99%1.09%1.49%3.48%2.67%N/AN/A0.01%0.22%0.93%2.67%
Profitability Indicator Ratios
Gross Profit Margin
48.99%48.01%47.54%47.17%46.55%36.68%39.33%35.62%36.75%38.30%41.54%41.54%
Operating Profit Margin
13.32%12.47%11.73%9.87%10.24%9.94%7.50%7.34%8.69%9.30%8.81%9.94%
Pretax Profit Margin
-0.81%8.31%7.90%2.43%-0.60%0.97%-25.11%-0.17%0.32%2.54%2.56%-0.60%
Net Profit Margin
0.70%6.78%5.78%1.80%0.01%0.73%-25.42%-0.87%0.71%2.00%1.95%0.01%
Effective Tax Rate
-185.71%18.47%26.77%25.99%-101.78%25%-1.25%-368.42%-110.25%19.36%25.67%-101.78%
Return on Assets
0.37%3.62%3.10%0.96%0.00%0.31%-11.11%-0.43%0.39%1.19%1.22%0.00%
Return On Equity
0.62%6.01%5.17%1.61%0.01%0.76%-33.10%-1.36%1.17%3.68%3.82%0.01%
Return on Capital Employed
7.62%7.14%6.78%5.74%4.59%4.68%3.72%4.19%5.55%6.41%6.47%4.59%
Liquidity Ratios
Current Ratio
2.182.151.761.421.431.030.98N/AN/AN/A0.691.03
Quick Ratio
1.951.891.531.130.730.830.830.990.620.550.560.83
Cash ratio
0.670.700.550.290.260.430.410.670.260.150.120.43
Days of Sales Outstanding
N/AN/AN/A29.53N/A22.8432.97N/A25.8226.7728.1622.84
Days of Inventory outstanding
21.7323.0121.1022.3221.5618.8024.5920.6019.5519.2819.6618.80
Operating Cycle
21.7323.0121.1051.8521.5641.6557.5620.6045.3746.0647.8221.56
Days of Payables Outstanding
42.4637.1337.3336.3334.9834.3837.9326.4932.3527.8131.5434.38
Cash Conversion Cycle
-20.73-14.12-16.2215.52-13.427.2719.63-5.8913.0118.2416.28-13.42
Debt Ratios
Debt Ratio
0.310.300.290.240.180.180.190.190.150.150.200.18
Debt Equity Ratio
0.520.490.480.400.440.440.590.600.440.490.620.44
Long-term Debt to Capitalization
0.340.330.320.280.300.300.370.370.300.320.320.30
Total Debt to Capitalization
0.340.330.320.290.300.300.370.370.300.330.380.30
Interest Coverage Ratio
1.408.629.928.292.261.160.78N/AN/AN/A1.311.16
Cash Flow to Debt Ratio
0.220.310.350.290.430.430.330.390.490.540.470.43
Company Equity Multiplier
1.681.661.661.672.372.432.973.152.953.093.112.37
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.130.170.190.130.190.180.150.150.130.140.150.18
Free Cash Flow / Operating Cash Flow Ratio
0.410.290.150.030.590.670.670.590.450.570.520.67
Cash Flow Coverage Ratio
0.220.310.350.290.430.430.330.390.490.540.470.43
Short Term Coverage Ratio
21.3231.6939.4233.51121.73108.5264.4029.9255.3458.792.24108.52
Dividend Payout Ratio
N/A20.66%27.61%90.47%15200%211.11%N/AN/A1.16%7.32%N/A211.11%